Bionix has been recapitalized by Argosy Private Equity
Bionix, LLC has been recapitalized by Argosy Private Equity.
Bionix, headquartered in Toledo, Ohio, was founded in 1984 after identifying a need for disposable ear curettes. Since then, it has become a leading developer of innovative healthcare products for ear, nasal, and wound care applications, among others, that uniquely meet physicians’ needs. Backed by a strong patent portfolio, Bionix is a premium brand for innovative features and superior performance relative to low-cost commodity alternatives. The company manufactures its products in the USA and serves customers in every region of the world.
Argosy Private Equity is a lower middle-market private equity firm which invests in manufacturing and business services companies through management and leveraged buy-outs, recapitalizations, corporate divestitures, growth financings and generational transitions of family-owned businesses.
Oaklins’ team in Cleveland served as the exclusive financial advisor to Bionix.


Talk to the deal team

Andrew P. Male
Managing Director
Cleveland, United StatesOaklins Citizens Capital Markets

Margaret E. Graham
Associate Director
Cleveland, United StatesOaklins Citizens Capital Markets

Savanna Roberts
Associate
Cleveland, United StatesOaklins Citizens Capital Markets
Related deals
Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Learn moreArgon Corporation has been acquired by Spectra
The private shareholders of Argon Corporation have sold the company to Spectra Aerospace and Defense, LLC (Spectra), a platform formed by Vance Street Capital.
Learn moreCommercial Tube Processing has been acquired by Nelson Global Products
Tube Processing Corporation has sold its division Commercial Tube Processing (CTP) to Nelson Global Products Inc.
Learn more